Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017

Liav Abraham Initiated (ABEO) at Strong Buy and Held Target at $800 on, Oct 10th, 2017

Liav Abraham of Citigroup, Initiated "Abeona Therapeutics Inc." (ABEO) at Strong Buy and Held Target at $800 on, Oct 10th, 2017.

Liav has made no other calls on ABEO in the last 4 months.



There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, 0 agree with Liav's Rating of Hold.



This is the rating of the analyst that currently disagrees with Liav


  • Matthew Eckler of "RBC Capital" Initiated at Buy and Held Target at $575 on, Friday, September 15th, 2017